Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial

NCT06693011 is registered in ClinicalTrials.gov with Cerus Endovascular, Inc. as lead sponsor.

NCT NCT06693011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06693011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contour Neurovascular System™ ContiNued Access Investigational Device EXempTion (IDE) Trial
Lead sponsor
Cerus Endovascular, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
June 10, 2025
Completion date
January 31, 2030
Enrollment
250 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral aneurysms